A balancing view: To screen or not to screen: Scoping out the issues

American Journal of Gastroenterology

Volumn 99, Issue 12, 2004, Pages 2295-2296

  Spechler, Stuart Jon ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL FEATURE; COST BENEFIT ANALYSIS; DISEASE COURSE; ENDOSCOPY; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ESOPHAGOSCOPY; ESOPHAGUS TUMOR; MASS SCREENING; NOTE; PATHOLOGY; PRECANCER; RISK ASSESSMENT;

ADENOCARCINOMA; BARRETT ESOPHAGUS; COST-BENEFIT ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS; RISK ASSESSMENT;

EID: 11144285886     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.41295_3.x     Document Type: Review

References (11)

1. Ries LAG, Eisner MP, Kosary CL, et al. (eds.). SEER cancer statistics review, 1975-2001. Bethesda, MD: National Cancer Institute, http://seer.cancer. gov/csr/1975-2001.
2. 2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000;11:231-8.
3. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
4. Locke GR, III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-56.
5. Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review. Gastroenterology 2001;122:26-33.
6. Spechler SJ. Managing Barrett's oesophagus. Br Med J 2003;326:892-4.
7. Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett's adenocarcinomas: A population-based study. Gastroenterology 2002;122:633-40.
8. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999;94: 2043-53.
9. Inadomi JM, Sampliner R, Lagergren J, et al. Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis. Ann Intern Med 2003;138:176-86.
10. Schoenfeld P, Cook D, Hamilton F, et al. An evidence-based approach to gastroenterology therapy. Gastroenterology 1998;114:1318-25.
11. Levinsky NG. The doctor's master. N Engl J Med 1984;311:1573-5.